Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

8.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.7K
Stages of Infection01:26

Stages of Infection

58.9K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
58.9K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

43
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
43
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

26
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
26
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

410
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
410
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.4K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

Responding Appropriately to Safety Signals in Infants Exposed to the 6-month BDLLfx/BDLCfz Regimen In Utero.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

The Lancet. Infectious diseases·2026
Same author

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

"Six months is a lot of time to lie": Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial.

Research square·2026
Same author

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

The Lancet. Infectious diseases·2025

Related Experiment Video

Updated: Sep 8, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.4K

A "Terminal Infection".

Jennifer Furin1

  • 1Division of Infectious Diseases, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 20, 2025
PubMed
Summary
This summary is machine-generated.

Antimicrobial resistance (AMR) significantly impacts patient care, especially for complex infections. This reflection explores collaborative strategies for infectious disease (ID) providers to manage challenging AMR cases effectively.

Keywords:
antibioticsantimicrobial resistancecollaborationinpatientpalliative care

More Related Videos

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

528
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.6K

Related Experiment Videos

Last Updated: Sep 8, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.4K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

528
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.6K

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Antimicrobial resistance (AMR) poses a significant threat to global health and patient outcomes.
  • Managing complex infections in patients with AMR presents substantial challenges for healthcare providers.
  • Current clinical practices require enhanced strategies to combat the rise of AMR.

Purpose of the Study:

  • To reflect on clinical encounters involving antimicrobial resistance (AMR).
  • To identify and propose potential collaborative approaches for managing complex infections.
  • To enhance the clinical management of patients affected by AMR.

Main Methods:

  • Retrospective analysis of clinical encounters with AMR.
  • Qualitative reflection on challenges faced by infectious diseases (ID) providers.
  • Exploration of interdisciplinary collaboration models.

Main Results:

  • Complex infections due to AMR require multifaceted management strategies.
  • Collaboration among healthcare professionals can improve patient outcomes.
  • Identifying specific collaborative approaches is crucial for effective AMR stewardship.

Conclusions:

  • Effective management of AMR necessitates a collaborative approach among ID providers and other specialists.
  • Further research into and implementation of collaborative models are essential for combating AMR.
  • Addressing AMR requires a unified and strategic effort within the clinical setting.